Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT

Heart Rhythm

Volumn 10, Issue 10, 2013, Pages 1471-1477

  Doyle, Colin L ^a   Huang, David T ^a   Moss, Arthur J ^a   Solomon, Scott D ^b   Campbell, Patricia ^b   McNitt, Scott ^a   Polonsky, Slava ^a   Barsheshet, Alon ^a   Aktas, Mehmet ^a   Tompkins, Christine ^a   Zareba, Wojciech ^a   Goldenberg, Ilan ^a,c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Cardiac resynchronizationtherapy; Cardiacremodeling; Right ventricular size; Rightventricle; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

ADULT; AGED; ANTIARRHYTHMIC ACTIVITY; ARTICLE; BODY SURFACE; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONVULSIVE THERAPY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART RIGHT VENTRICLE SIZE; HEART VENTRICLE SIZE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NONISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; QRS COMPLEX; SECONDARY ANALYSIS; SINUS RHYTHM;

BODY SURFACE AREA; BSA; CARDIAC REMODELING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR; CI; CONFIDENCE INTERVAL; CRT; CRT-D; HAZARD RATIO; HR; ICD; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; LEFT VENTRICLE; LV; MADIT-CRT; MULTICENTER AUTOMATIC DEFIBRILLATOR IMPLANTATION TRIAL WITH CARDIAC RESYNCHRONIZATION THERAPY; NEW YORK HEART ASSOCIATION; NYHA; RIGHT VENTRICLE; RIGHT VENTRICULAR END-DIASTOLIC AREA; RIGHT VENTRICULAR FRACTIONAL AREA CHANGE; RIGHT VENTRICULAR SIZE; RV; RVEDA; RVFAC; VENTRICULAR FIBRILLATION; VENTRICULAR TACHYCARDIA; VF; VT;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION; VENTRICULAR REMODELING;

EID: 84884633341     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2013.07.029     Document Type: Article

References (24)

1. T. Shiga, and H. Kasanuki Drug therapy for ventricular tachyarrhythmia in heart failure Circ J 71 Suppl A 2007 A90 A96
2. C.M. Tracy, A.E. Epstein, and D. Darbar 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 60 2012 1297 1313
3. A.J. Moss, W.J. Hall, and D.S. Cannom Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
4. V.A. Medina-Ravell, R.S. Lankipalli, and G.X. Yan Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation 107 2003 740 746
5. S.L. Higgins, P. Yong, and D. Sheck Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. Ventak CHF Investigators J Am Coll Cardiol 36 2000 824 827
6. A. Arya, M. Haghjoo, and M.R. Dehghani Effect of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator Heart Rhythm 2 2005 1094 1098
7. P. Kies, J.J. Bax, and S.G. Molhoek Effect of left ventricular remodeling after cardiac resynchronization therapy on frequency of ventricular arrhythmias Am J Cardiol 94 2004 130 132
8. L. Di Biase, M. Gasparini, and M. Lunati Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: The InSync ICD (implantable cardioverter-defibrillator) Italian Registry J Am Coll Cardiol 52 2008 1442 1449
9. A. Barsheshet, P.J. Wang, and A.J. Moss Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy) J Am Coll Cardiol 57 2011 2416 2423
10. S.D. Solomon, E. Foster, and M. Bourgoun Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: Multicenter Automatic Defibrillator Implantation Trial: Cardiac Resynchronization Therapy Circulation 122 2010 985 992
11. M.K. Aktas, D.D. Kim, and S. McNitt Right ventricular dysfunction and the incidence of implantable cardioverter-defibrillator therapies Pacing Clin Electrophysiol 32 2009 1501 1508
12. A.J. Moss, M.W. Brown, and D.S. Cannom Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT): design and clinical protocol Ann Noninvasive Electrocardiol 10 2005 34 43
13. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
14. T.G. Di Salvo, M. Mathier, M.J. Semigran, and G.W. Dec Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure J Am Coll Cardiol 25 1995 1143 1153
15. P. Meyer, G.S. Filippatos, and M.I. Ahmed Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure Circulation 121 2010 252 258
16. S. Ghio, A. Gavazzi, and C. Campana Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure J Am Coll Cardiol 37 2001 183 188
17. P. de Groote, A. Millaire, and C. Foucher-Hossein Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure J Am Coll Cardiol 32 1998 948 954
18. C.V. Bourantas, H.P. Loh, and T. Bragadeesh Relationship between right ventricular volumes measured by cardiac magnetic resonance imaging and prognosis in patients with chronic heart failure Eur J Heart Fail 13 2011 52 60
19. S.R. Mehta, J.W. Eikelboom, and M.K. Natarajan Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction J Am Coll Cardiol 37 2001 37 43
20. L.A. Zornoff, H. Skali, and M.A. Pfeffer Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction J Am Coll Cardiol 39 2002 1450 1455
21. P. Campbell, M. Takeuchi, and M. Bourgoun Right ventricular function, pulmonary pressure estimation, and clinical outcomes in cardiac resynchronization therapy Circ Heart Fail 6 2013 435 442
22. J.S. Gottdiener, J. Bednarz, and R. Devereux American Society of Echocardiography recommendations for use of echocardiography in clinical trials J Am Soc Echocardiogr 17 2004 1086 1119
23. P. Maury Why is the right ventricular outflow tract so arrhythmogenic? (. or is it really?.) Heart 97 2011 1631 1633
24. L.G. Rudski, W.W. Lai, and J. Afilalo Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography J Am Soc Echocardiogr 23 2010 685 713 quiz 786-788